With around 50 million people worldwide suffering from the debilitating neurological disease called epilepsy, the chance for self-harm due to an abrupt seizure is always high. Now, while medical treatment and medicine can offer many patients a potential seizure-free life, there are still quite a lot of sufferers who find it hard to have a normal life, when the next seizure is just waiting around the corner. Though, sometimes where medicine lags, technology picks up to create a symbiosis of innovation that improves quality of life.
Researchers from Ben-Gurion University developed a truly unique device, aiming to give to millions of patients around the world a sense of normality again. The researchers have brought to life a wearable device called Epiness that utilizes machine-learning algorithms to accurately predict and alarm of an upcoming epileptic seizure. The device will be further developed and commercialized through Israeli startup NeuroHelp, which is part of BGU’s Oazis accelerator program, and founded by BGN Technologies and Dr. Oren Shriki, who heads the Department of Cognitive and Brain Sciences at BGU.
Machine learns, then machine predicts
Epilepsy is a highly pervasive, and at times debilitating neural disease. Up to 30% of patients do not adequately respond to anti-epileptic drugs and live under constant fear of impending seizures. For such patients, a viable seizure prediction device could offer a substantial improvement in quality of life, enabling them to avoid seizure-related injuries. Current seizure alarm devices can detect a seizure in real-time but are unable to provide advanced warnings of impending seizures, while Epiness can detect and alert of a pending seizure up to an hour before it happens. This allows patients to be better prepared for seizures, enabling them not only a sense of control and safety but a higher quality of life.
"Epileptic seizures expose epilepsy patients to various preventable hazards, including falls, burns and other injuries," said Dr. Oren Shriki. "Unfortunately, currently there are no seizure-predicting devices that can alert patients and allow them to prepare for upcoming seizures. We are therefore very excited that the machine-learning algorithms that we developed enable accurate prediction of impending seizures up to one hour prior to their occurrence. Since we have also shown that our algorithms enable a significant reduction in the number of necessary EEG electrodes, the device we are developing is both accurate and user friendly. We are currently developing a prototype that will be assessed in clinical trials later this year."
Epiness is a seizure prediction and detection device that is based on a new, ground-breaking combination of EEG-based monitoring of brain activity together with proprietary machine-learning algorithms. The device combines a wearable EEG device with state-of-the-art software that minimizes the number of necessary EEG electrodes and optimizes electrode placement on the scalp. The sophisticated machine-learning algorithms are designed to filter noise that is not related to brain activity, extract informative measures of the underlying brain dynamics, and distinguish between brain activity before an expected epileptic seizure and brain activity when a seizure is not expected to occur.
The new algorithm was developed and tested using EEG data from a large dataset of people with epilepsy that were monitored for several days prior to surgery. The patient data were divided into short segments that were either preictal (pre-seizure) or inter-ictal.
"Epilepsy that is not adequately controlled by medication is prevalent, amounting up to 30% of epilepsy cases, and therefore, an accurate, easy to use seizure predicting device is a highly necessary unmet medical need," stated Dr. Hadar Ron, Chairperson of NeuroHelp. "Current seizure alert devices can detect seizures while they are happening, and most of them depend on changes in movement, such as muscle spasms or falls. Epiness is unique in that it can predict an upcoming seizure and allow the patients and their caretakers to take precautionary actions and prevent injuries. It is also the only device that is based on brain activity rather than muscle movements or heart rate. We are confident that Epiness will be a valuable tool in the management of drug-resistant epilepsy."
Several machine learning algorithms with differing complexities were trained on pre-allocated training data (comprising 80% of the initial EEG data), and their prediction performance, as well as electrode-dependent performance, was assessed on the remaining 20% of the data. The algorithm with the best prediction performance reached a 97% level of accuracy, with near-optimal performance maintained (95%) even with relatively few electrodes.
Josh Peleg, CEO of BGN Technologies, the technology transfer company of BGU, added, "NeuroHelp, a spin-off of BGN Technologies, was recently founded as part of BGU's Oazis accelerator, formed by the Yazamut360 entrepreneurship center of BGU, to further develop and commercialize their innovative solution for the benefit of people suffering from epilepsy. Earlier this month, NeuroHelp won first prize in the SiliconNegev startup competition, an important recognition of the outstanding potential of this technology, which is based on a unique combination of brain research and artificial intelligence know-how developed at Dr. Shriki's laboratory."